CVRx, Inc.
NASDAQ:CVRXMedical - Devices
+$0.11 today
- Market cap
- $69.79M
- Beta
- 0.77
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$2.00
Volume 0.37M
Average 0.30M
CVRX Net Income
Bottom-line profit, the starting point for calculating cash from operations.
CVRx, Inc.NASDAQ: CVRX
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income dips below year-ago levels
Q1 FY2026 net income of $13.12M (cash outflow) fell 4.7% year over year, behind the +2.2% change in trailing-twelve-month net income. Sequentially, it rose 9.9% from the prior quarter. Over 3 fiscal years it compounded at +8.8% a year.
Context
- Net income amounted to 94.1% of revenue in FY2025, down 22.8 pp from a year earlier.
- Net income grew in size in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 5 analysts of -$53.51M (+0.4%) for the fiscal year ending Dec 2026, a step up from the -11.1% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$13.12M+9.9% QoQ
- Last fiscal yearDec 2025
- -$53.31M-11.1% YoY
- LTMMar 2026
- -$52.66M+2.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -4.7% | -5.6% | -0.9 pp |
| 1 year | -11.1% | +0.4% | +11.5 pp |
| 3-year CAGR | +8.8% | -3.1% | -11.9 pp |
| 5-year CAGR | -11.2% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (53.31M) USD
- Year-over-year change
- +11.1%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (53.31M) | +11.1% |
| FY2024 | 2024-12-31 | (59.97M) | -45.5% |
| FY2023 | 2023-12-31 | (41.2M) | +0.6% |
| FY2022 | 2022-12-31 | (41.43M) | +3.8% |
| FY2021 | 2021-12-31 | (43.08M) | — |
Net Income vs competitors
How CVRX compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +2.2% is the 8th highest of 10, against a peer median of +40.2%.
- Net income amounts to 89.1% of revenue for CVRX, versus a peer median of 61.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $104.19M USD | +117.6% | +3.5% | 71.9% | |
| LTM Mar 2026 | $87.19M USD | +17.8% | — | 214.2% | |
| LTM Dec 2025 | $75.02M USD | +40.2% | -10.7% | 576.1% | |
| LTM Mar 2026 | $52.66M USD | +2.2% | +8.8% | 89.1% | |
| LTM Mar 2026 | €45.62M EUR | +51.2% | -14.2% | 339.4% | |
| LTM Mar 2026 | $37.25M USD | -24.6% | -23.6% | 46.8% | |
| LTM Mar 2026 | $35.6M USD | +101.3% | — | 61.6% | |
| LTM Mar 2026 | $15.16M USD | +21.1% | +33.9% | 5.3% | |
| LTM Mar 2026 | $9.56M USD | -49.7% | -28.5% | 4.3% | |
| LTM Mar 2026 | $4.24M USD | +113.0% | — | 9.6% | |
| Peer median (excluding CVRX) | — | +40.2% | -12.4% | 61.6% | |
Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (43.08M) | (41.43M) | (41.2M) | (59.97M) | (53.31M) |
| Depreciation & Amortization | 168K | 412K | 522K | 619K | 756K |
| Deferred Income Tax | 14.62M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.91M | 3.89M | 6.3M | 19.05M | 11.05M |
| Change in Working Capital | (1.58M) | (5.57M) | (4.81M) | 949K | 1M |
| Accounts Receivables | (1.28M) | (2.94M) | (2.05M) | (1.72M) | (1.4M) |
| Inventory | (537K) | (3.08M) | (4.03M) | (1.12M) | (98K) |
| Accounts Payables | 27K | 1.21M | 165K | 698K | 1.25M |
| Other Working Capital | 207K | (761K) | 1.1M | 3.09M | 1.25M |
| Other Non-Cash Items | 229K | 25K | 158K | 203K | 327K |
| Operating Cash Flow | (27.73M) | (42.68M) | (39.02M) | (39.14M) | (40.17M) |
| Capital Expenditures | (1.18M) | (685K) | (591K) | (1.36M) | (580K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.18M) | (685K) | (591K) | (1.36M) | (580K) |
| Debt Repayment | (21.3M) | 7.5M | 22.5M | 20M | 0 |
| Common Stock Issued | 133.16M | 771K | 1.66M | 32.52M | 10.52M |
| Common Stock Repurchased | (1K) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 23K | (7K) | 1.48M | 3.35M | 0 |
| Financing Cash Flow | 111.88M | 7.49M | 23.98M | 55.87M | 10.52M |
| Effect of Forex Changes | (8K) | (9K) | 3K | (1K) | 5K |
| Net Change in Cash | 82.96M | (35.88M) | (15.63M) | 15.36M | (30.23M) |
| Free Cash Flow | (28.92M) | (43.36M) | (39.61M) | (40.51M) | (40.75M) |
CVRx, Inc.
NASDAQ:CVRX
Intrinsic Alpha fair value
Locked
Current Price
$2.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.